Any substance chemically similar to fentanyl would automatically become a Schedule I controlled substance. This means tougher enforcement against new synthetic opioids linked to overdose deaths, but also more barriers to researching these drugs.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Stopping Overdoses of Fentanyl Analogues Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on the Judiciary.
Latest action on S. 165: Read twice and referred to the Committee on the Judiciary.
Who this affects: This bill affects anyone involved with fentanyl-like substances, from drug traffickers to medical researchers. Law enforcement gains a broader tool to prosecute synthetic opioid cases. Scientists studying these substances face stricter requirements. People charged with possession or distribution of fentanyl-like drugs face Schedule I penalties.
Why this matters: Fentanyl and its chemical cousins have caused tens of thousands of overdose deaths in the United States. Illegal drug makers often tweak fentanyl's structure slightly to create new versions that fall outside current law. This bill tries to close that loophole by banning all structurally similar substances at once, but it also raises questions about research access and proportional sentencing.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
